Drug development is fraught with challenges, as evidenced by the high rate of candidate failures during clinical trials due to inadequate evidence or ambiguous data. However, the landscape is shifting with the rise of collaborative data initiatives. These initiatives...
Data is getting generated at the fastest pace in human history. Enterprise customers are growing their data footprint at a rate of 30 to 40 percent year over year. This generates vast amounts of data every day. This exponential data growth begs the question: Do...
Digital transformation has led to an explosion in data volumes, with an expected 180 zettabytes of data by 2025, prompting a shift away from traditional centralized data control. IT departments typically control data infrastructure, but decentralization, where data...
The evolution of cloud services from mere storage and processing solutions to adaptive cloud architectures is revolutionizing how enterprises approach AI workloads, dynamically tailoring resources and revolutionizing cost efficiency. Moving beyond a simplistic...
During the pandemic, AI swiftly repurposed drugs like baricitinib for COVID-19, saving time and ensuring rapid treatment access. AI predicts compound interactions, reducing drug discovery timelines and costs significantly. Despite its success within some...
